Skip to main content
Tech.euFundingExplorerBeta

Calico Biosystems

The company is dedicated to enhancing the clinical efficacy of anti-cancer drugs during the pre-clinical stage in response to the high failure rate of therapeutics and the limited patient response to approved cancer treatments.

Total raised
€157k
€156,621
Funding rounds
1
Investors
1
distinct backers
Active since
2024-06
latest 2024-06

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood33
base rate 30% for Other
  • In typical raise window
  • Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2024-06-25Other€157kVenture KickView deal →

Investors

1

Related news

Similar companies

same sector or country